Table 3 Risk subsequent muscular involvement according to aldolase at baseline after adjusting for other characteristics at baseline
From: Aldolase predicts subsequent myopathy occurrence in systemic sclerosis
Hazard ratio (95% CI) | P | |
|---|---|---|
Aldolase > 9 U/L | 10.3 (2.3 to 45.5) | < 0.001 |
Age (per additional year) | 0.98 (0.93 to 1.04) | 0.68 |
Female | 0.63 (0.07 to 5.18) | 0.67 |
Diffuse form of disease | 1.23 (0.27 to 5.49) | 0.78 |
Duration of disease (per additional year) | 0.97 (0.90 to 1.05) | 0.57 |